title: Isolation and characterization of HL-60 cells resistant to nitroprusside-induced differentiation.
abstract: Sodium nitroprusside and sodium nitrite, which generate nitric oxide and increase the intracellular cGMP concentration, and 8-bromo-cGMP, a membrane-permeable cGMP analog, induce myelomonocytic differentiation of HL-60 cells (Boss, G. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7174-7178). We have selected HL-60 cells resistant to nitroprusside-induced differentiation as assessed by acquisition of the OKM-1 antigen, reduction of nitro blue tetrazolium, and morphologic maturation. The variant cells were also resistant to differentiation induced by sodium nitrite and two cGMP analogs but still differentiated in response to other inducing agents such as dimethyl sulfoxide and cAMP analogs and showed the same changes in c-myc and c-fos expression in response to the latter drugs as occurred in parental cells. We studied the early steps of the NO/cGMP signal transduction pathway in the variant cells and found that basal and nitroprusside-stimulated guanylate cyclase activity was similar in parental and variant cell extracts and that nitroprusside increased the intracellular cGMP concentration to the same extent in parental and variant cells. As part of these studies we found that HL-60 cells expressed only alpha 2 and beta 2 guanylate cyclase mRNA; the abundance of these two mRNA species was similar in parental and variant cells. Neither nitroprusside nor 8-bromo-cGMP changed the intracellular calcium concentration in parental or variant cells. The data suggest that the defect in the variant cells is after guanylate cyclase activation in the NO/cGMP transduction pathway and that the cGMP and cAMP transduction pathways operate independently in inducing differentiation of HL-60 cells.
authors.affiliation: Department of Medicine, University of California at San Diego, La Jolla 92093-0652.
authors.forename: R B
authors.initials: RB
authors.lastname: Pilz
authors.forename: M
authors.initials: M
authors.lastname: Berjis
authors.forename: S D
authors.initials: SD
authors.lastname: Idriss
authors.forename: J S
authors.initials: JS
authors.lastname: Scheele
authors.forename: M
authors.initials: M
authors.lastname: Suhasini
authors.forename: L
authors.initials: L
authors.lastname: Gao
authors.forename: I E
authors.initials: IE
authors.lastname: Scheffler
authors.forename: G R
authors.initials: GR
authors.lastname: Boss
mesh_terms: D002454:Cell Differentiation / Q000187:drug effects*; D002455:Cell Division; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004351:Drug Resistance; D016762:Genes, fos; D016259:Genes, myc; D006162:Guanylate Cyclase / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009599:Nitroprusside / Q000494:pharmacology*; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D012333:RNA, Messenger; D009599:Nitroprusside; D000242:Cyclic AMP; D006162:Guanylate Cyclase; D006152:Cyclic GMP